Replies to post #538033 on NorthWest Biotherapeutics Inc (NWBO)

[underpar71]

I agree with your first paragraph, not the second. Any potential buyer could obviously buy 4.9% in open market at the current prices, why wouldn't they, and then make an offer for the rest if buyout is the direction. As far as pricing/value for a buyout? I believe the market would help dictate that. LP would likely not even engage in conversation with offers based on current share price. We are probably $4 below current known value when you include the data, patents, manufacturing status. I could see $10-15 offer with what is currently known, and once applications for approval are submitted. After approval it would be much higher.

[Kaizenman]

VI: I believe your hypothesis regarding retail soaking up the float is likely correct and "they" may need to go to page 2 of the playbook and sponsor a large upward move to get the number of shares to shake out. Page 1 of the playbook has been used so much that it is almost futile at this point for "them". JMO

Peace.

[biosectinvestor]

Yes, re other methods including the merger option with a SPAC, has occurred to me though it is fading a bit. But you really do never know. Great post.

[VMLG17]

Viking, as I’m sure you and most others are aware, forming a SPAC or some other new corporate structure, even alongside a partnership/milestone-based buyout, is right up LP’s alley. I would expect this sort of strategy before a reverse split if it’s needed.